SynapCell to unveil unprecedented advances in Epilepsy at the Antiepileptic Drug Trials Conference.
Contact us to select a convenient time for you to meet Corinne, CEO and founder of SynapCell.

Conference Purpose

• The conference focuses on issues surrounding AEDD development, ranging from preclinical discoveries to clinical evaluations. Topics to be covered at the conference include:
• The processes by which new drugs are discovered, including discussing new animal models and molecular targets
• Translational models in the epilepsy space
• New regulatory pathways for epilepsy approval, including orphan indications, and extrapolation from adults to children
• Assessing patient suitability for epilepsy trials, including centralized patient interviews
• New objectives and legislation that have an impact on AED development
• Novel trial designs that reduce placebo exposure
• New methods and devices for seizure counting
• Outlining the drugs and devices in preclinical and clinical development for epilepsy